Green Cross Holdings Corporation
KRX:005250.KS
16,220 (KRW) • At close November 1, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Green Cross Holdings Corporation |
Symbool | 005250.KS |
Munteenheid | KRW |
Prijs | 16,220 |
Beurswaarde | 728,832,399,600 |
Dividendpercentage | 1.95% |
52-weken bereik | 12,940 - 18,490 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Il-Sup Huh Ph.D. |
Website | https://www.greencross.com |
An error occurred while fetching data.
Over Green Cross Holdings Corporation
Green Cross Holdings Corporation operates as a biotechnology company. The company provides plasma derivatives, prescription drugs, over the counter drugs, and hunter syndrome drugs; and vaccines for hemorrhagic fever, varicella, hepatitis-B, and flu. It also researches and develops oncology, immunology, and cell therapy products; and offers recombinant protein treatment for
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (KRW)
Cijfers zijn in miljoenen (KRW)